The use of complementary and alternative medicine for liver disease: Part II

Nutrition in Clinical Practice

Volumn 28, Issue 2, 2013, Pages 277-279

  Mullin, Gerard E ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELIDONIUM EXTRACT; KAVA; KAVA EXTRACT; MATRICARIA CHAMOMILLA EXTRACT; MENTHA PULEGIUM EXTRACT; NICOTINIC ACID; NUTRACEUTICAL; PYRROLIZIDINE ALKALOID; VISCUM ALBUM EXTRACT; XIAO CHAI HU TANG;

ACUTE LIVER FAILURE; ALTERNATIVE MEDICINE; ARTICLE; CHELIDONIUM; CHINESE MEDICINE; DIET SUPPLEMENTATION; DYSPEPSIA; FOOD AND DRUG ADMINISTRATION; FULMINANT HEPATIC FAILURE; GARCINIA CAMBOGIA; GERMANDER; GOUT; HUMAN; ILEX PARAGUARIENSIS; IRRITABLE COLON; LIVER DISEASE; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; PARSLEY; SPIRAEA; TEA; WEIGHT CONTROL; WEIGHT REDUCTION;

DIETARY SUPPLEMENTS; HUMANS; LIVER; LIVER DISEASES; NIACIN; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; VITAMINS;

EID: 84875268478     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612475133     Document Type: Article

References (29)

1. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005 ; 129: 512-521
2. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004 ; 10: 1018-1023
3. Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012 ; 107: 1380-1387
4. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbalife® hepatotoxicity: a tabular compilation of reported cases. Liver Int. 2012 ; 32 (10). 1543-1556
5. Hsu LM, Huang YS, Tsay SH, Chang FY, Lee SD. Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. J Chin Med Assoc. 2006 ; 69: 86-88
6. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol. 1997 ; 92: 703-704
7. Hiramatsu K, Sakata H, Horita Y, et al. Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine. Aliment Pharmacol Ther. 2012 ; 36: 575-586
8. Galloway JH, Marsh ID, Bittiner SB, et al. Chinese herbs for eczema, the active compound?. Lancet. 1991 ; 337: 566
9. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009 ; 65: 331-341
10. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis. 2007 ; 11: 577-596
11. Ammon HP, Kelber O, Okpanyi SN. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomedicine. 2006 ; 13: 114-121
12. BenniTeschke R, Glass X, Schulze J. Herbal hepatotoxicity by greater celandine (Celidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol. 2011 ; 61 (3). 282-291
13. Brent J. Three new herbal hepatotoxic syndromes. Clin Toxicol. 1999 ; 37 (6). 715-719
14. Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int. 2010 ; 30: 1270-1279
15. Pittler MH, Edzard E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2001 ; (4). CD003383
16. Teschke R, Schwarzenboeck A, Hennermann K-H. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol. 2008 ; 20: 1182-1193
17. Nelson SE. Persephone's seeds: abortifacients and contraceptives in ancient Greek medicine and their recent scientific appraisal. Pharm Hist. 2009 ; 51 (2). 57-69
18. Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996 ; 124: 726-734
19. LewisCJ. FDA advises dietary supplement manufacturers to remove comfrey products from the market [letter to industry trade organizations, professional organizations, and nonprofit groups]. July6, 2001. http://www.cfsan.fda.gov/ ∼dms/dspltr06.html
20. Chen Z, Huo JR. Hepatic veno-occulsive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med. 2010 ; 68 (6). 252-260
21. Herbalife. http://company.herbalife.com/Content/en-US/pdf/about- herbalife/press-room/Herbalife-Corporate-Profile-October-2009.pdf
22. Jóhannsson M, Ormarsdóttir S, Olafsson S. Hepatotoxicity associated with Herbalife® products. Laeknabladid. 2010 ; 96 (3). 167-172
23. Appelhans K, Smith C, Bejar E, Henig YS. Revisiting acute liver injury associated with Herbalife products. World J Hepatol. 2011 ; 3: 275-277
24. Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to Hydroxycut: a case series. Am J Gastroenterol. 2010 ; 105: 1561-1566
25. Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. Liver Int. 2011 ; 31: 595-605
26. ClelandRLGrossWCKossLDDaynardMMuoioKM. Federal Trade Commission staff report Sept 2002: weight-loss advertising: an analysis of current trends. http://www.ftc.gov/bcp/reports/weightloss.pdf
27. McCormack PL, Keating GM. Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs. 2005 ; 65 (18). 2719-2740
28. Henkin Y, Johnson KC, Segrest JP. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. JAMA. 1990 ; 264 (2). 241-243
29. Mullin GE, Greenson JK, Mitchell MC. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med. 1989 ; 111 (3). 253-255